Amp Capital Investors LTD Gilead Sciences, Inc. Transaction History

Amp Capital Investors LTD

$0
Q4 2022

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $17.7 Million - $20.1 Million	-273,347 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $5.41 Million - $5.84 Million	-79,959 Reduced 22.63%	273,347 $19.1 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $1.5 Million - $1.64 Million	-23,697 Reduced 6.29%	353,306 $24.3 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $4.26 Million - $4.86 Million	-71,022 Reduced 15.85%	377,003 $24.4 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $1.35 Million - $1.53 Million	-23,763 Reduced 5.04%	448,025 $25.4 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $4.75 Million - $5.97 Million	-76,493 Reduced 13.95%	471,788 $29.3 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $2.97 Million - $3.45 Million	41,074 Added 8.1%	548,281 $40.9 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $6.96 Million - $8.92 Million	-111,198 Reduced 17.98%	507,207 $38.5 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $74,128 - $81,539	1,203 Added 0.19%	618,405 $40.2 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $5.88 Million - $6.49 Million	-94,008 Reduced 13.22%	617,202 $38.8 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $2.36 Million - $2.65 Million	-38,134 Reduced 5.09%	711,210 $47.7 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $2.35 Million - $2.64 Million	37,643 Added 5.29%	749,344 $47.7 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $1.71 Million - $2.24 Million	28,303 Added 4.14%	711,701 $44 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $152,467 - $168,809	2,139 Added 0.31%	683,398 $52.3 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $1.56 Million - $1.82 Million	-23,985 Reduced 3.4%	681,259 $48.3 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $911,956 - $1.11 Million	12,520 Added 1.81%	705,244 $52.7 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $9.06 Million - $10.6 Million	-127,368 Reduced 15.53%	692,724 $49.6 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.92 Million - $2.27 Million	26,563 Added 3.35%	820,092 $66.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	793,529	793,529 $56.2 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.

Account